Producer
Terumo Corporation
Japanese medical-device maker; pen needles and injection systems.
5
Inputs supplied
4
Goods downstream
1
Facilities
0
Stories
What they make
5 inputs Terumo Corporation supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
manufactured
Pen Needles (Subcutaneous Injection) →
manufactured
Apheresis & Cell-Processing Systems →
manufactured
Apheresis & Cell-Processing Systems →
manufactured
Hollow-Fiber Membrane Oxygenator (Heart-Lung / ECMO) →
manufactured
Hollow-Fiber Membrane Oxygenator (Heart-Lung / ECMO) →
Where it shows up
Goods downstream
Essential goods that depend on something Terumo Corporation makes, pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map, where this supply-chain role fits within their broader business.
Cardiac and Vascular
50%Medical Care Solutions
30%Blood and Cell Technologies (Terumo BCT)
20%
Intelligence
What's known
Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.
Did you know2024
Terumo is known for needles, syringes and catheters. But through Terumo BCT it makes the Spectra Optia apheresis system — and that one machine sits under two completely different essential-medicine supply chains. In a blood center it collects source plasma and blood components (the raw material of immunoglobulins, albumin and clotting factors). In a cell-therapy lab it performs the leukapheresis that harvests a cancer patient's own T-cells, and the washing/selection steps, at the very start of CAR-T manufacturing. So the company that supplies routine hospital injection consumables is also critical front-end infrastructure for the most advanced cancer cell therapies on the market — a needle-and-syringe maker quietly standing at the gateway of CAR-T production.
Terumo BCT ↗Concentration2024
Terumo's CAPIOX hollow-fiber membrane oxygenators make it one of only a handful of companies — with Getinge/Maquet, LivaNova and Medtronic — that supply the world's "artificial lungs": the oxygenators in heart-lung bypass machines and ECMO life-support circuits. Every open-heart operation routes the patient's entire blood volume through one of these devices, and during COVID-19 ECMO oxygenators became a documented global shortage point. The oxygenator depends on specialty polymethylpentene hollow-fiber membrane, itself made by very few suppliers. Cardiac surgery and the most intensive form of respiratory life support both rest on a tiny oxygenator supply base in which Terumo is a principal node.
Terumo Corporation ↗Origin2024
Terumo's name means "thermometer." The company was founded in Tokyo in 1921 as Sekisen Ken-onki ("red-line thermometer") to manufacture clinical thermometers domestically, after the First World War cut Japan off from German-made medical thermometers. Its founding backers included Kitasato Shibasaburo, the renowned bacteriologist (co-discoverer of the tetanus and diphtheria antitoxin work). From that wartime import-substitution start — make at home what the supply shock removed — Terumo grew over a century into a global medical-device group spanning interventional cardiology, hospital injection systems, and blood and cell technologies. The same import-shock logic that created it now describes the chokepoints it occupies.
Terumo Corporation ↗